Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Aegis Logistics among 4 stocks that closed below VWAP
Four Nifty500 stocks, Balkrishna Industries, Aegis Logistics, PhysicsWallah and OneSource Specialty Pharma, closed over 3% below VWAP, highlighting bearish sentiment and weakening price momentum.
Poly Medicure among 4 stocks that closed below VWAP
Four Nifty500 stocks, Poly Medicure, Aditya Birla Real Estate, Siemens Energy India, and Onesource Specialty Pharma, closed over 2% below their VWAP on July 3, indicating potential bearish momentum and heightened selling pressure, according to technical scan data.
Bernstein backs Zydus, Lupin and Sun Pharma on innovation shift
Nandan Kulkarni, Director–India Healthcare & Senior Research Analyst at Bernstein, sees strong opportunities in CDMOs, specialty therapies, biosimilars and licensing deals. While favouring Zydus, Lupin and Sun Pharma, he remains cautious on Biocon and Mankind Pharma, and argues that India's shift from generics to innovation could drive the next phase of growth for the pharma industry.
AI-led global earnings pressure India; opportunities in power, pharma: Conrad Saldanha
Neuberger Berman MD & Portfolio Manager Conrad Saldanha discusses why AI-driven earnings growth in the US, Korea and Taiwan continues to attract capital, shares his outlook on India, and highlights opportunities in power infrastructure, airports, specialty pharma and select financials.
Anupam Rasayan to acquire up to 43 pc stake in Bliss GVS Pharma for around Rs 1,369 cr
Specialty chemicals maker Anupam Rasayan India is set to acquire up to 43.3% of Bliss GVS Pharma for an estimated Rs 1,369.51 crore, with an open offer for an additional 26%. This strategic move aims to strengthen Anupam Rasayan's presence across the pharmaceutical value chain, from key starting materials to finished dosage formulations.
Five Stocks To Buy: Aurobindo Pharma, Tata Communications, Graphite India And More | May 18, 2026
Top picks include pharma majors Aurobindo Pharma and OneSource Specialty Pharma, agrochemical player Sumitomo Chemical India, telecom giant Tata Communications, and industrial manufacturing firm Graphite India.
OneSource Specialty Pharma shares fall as Q4 profit plunges 95%, margin halves
OneSource Specialty Pharma reports a sharp decline in Q4FY26 profit, EBITDA falls by 50%, FY26 swings to net loss, finance costs jump, shares fall over 5%.
OneSource Specialty Pharma receives EU GMP certification for sterile product division
Shares of Onesource Specialty Pharma Ltd ended at ₹1,765.00, down by ₹63.20, or 3.46%, on the BSE.
Onesource Specialty Pharma shares gain after equity worth ₹408 crore changes hands in block deals
The collaboration is to ensure reliable commercial supply from Onesource's USFDA approved flagship site in Bengaluru, the company said.
Chennai Petroleum Corporation Ltd leads losers in 'A' group
Kaveri Seed Company Ltd, ITI Ltd, Mangalore Refinery And Petrochemicals Ltd and OneSource Specialty Pharma Ltd are among the other losers in the BSE's 'A' group today, 18 March 2026.
Newgen Software Technologies Ltd leads losers in 'A' group
Firstsource Solutions Ltd, Latent View Analytics Ltd, OneSource Specialty Pharma Ltd and Le Travenues Technology Ltd are among the other losers in the BSE's 'A' group today, 20 February 2026.
Stocks to Watch Today: Gaudium IVF, Vishal Mega Mart, Netweb Tech, MSTC, Brigade Enterprises, Hindalco, Zaggle Prepaid in focus on 27 February
Stocks to Watch, 27 Feb: Stocks like Vishal Mega Mart, Gujarat Mineral Development Corporation, Netweb Technologies, MSTC, Engineers India, Onesource Specialty Pharma, Greaves Cotton, Hindalco Industries, and Indian Railway Finance Corporation will be in focus on February 27.